Full-Time

Manager – Regulatory Artwork & Labelling Implementation

Rali

Posted on 4/1/2025

AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Junior, Mid

Sant Cugat del Vallès, Barcelona, Spain

Minimum of three days per week in the office.

Category
Legal
Risk & Compliance
Legal & Compliance
Requirements
  • University Degree in Science or related discipline
  • 1-3 years of pharmaceutical experience, preferably regulatory experience, preferably working with labeling and packaging/artwork management
  • Knowledge of labeling regulations and guidance’s
  • Keen attention to detail and accuracy
  • Excellent verbal and written communication skills
  • Multi-cultural awareness and sensitivity; demonstrated experience effectively communicating and negotiating in diverse cultures
  • Ability to think strategically, appropriately assess risks and formulate strategies to manage risk
  • Must demonstrate competencies in: Building Relationships (works well across formal and informal networks), Negotiation Skills (good listener; able to build a consensus), Critical Information Seeking (works well across formal and informal networks), Rational Persuasion (able to distill an issue to its key components and suggest solutions), Interpersonal Awareness (aware of how actions affect other people)
Responsibilities
  • Ensure all work is performed in accordance with established procedures, regulatory requirements, and GxPs.
  • Point of contact for the management of all labelling/artwork requests that require market/regulatory approval in US and EU centralized procedure, such as the creation, approval, and implementation of commercial printed labeling in collaboration with various functions.
  • Coordinate and/or lead the development and lifetime maintenance of packaging component labeling for commercial products, including introduction of new packs and new product launches, updates to existing packs, and mock-ups for regulatory submissions.
  • Provide tactical and strategic guidance to product labeling teams regarding regulatory requirements for packaging component labeling.
  • Understand industry labeling trends related to packaging and labeling content and implementation, reviewing competitor and other labeling.
  • Interpret US and EU labeling regulations and guidance, determining company impact and providing comments as appropriate.
  • Contribute the regulatory labeling perspective in support of novel packaging design initiatives.
  • Ensure proper version control and document integrity of packaging component labeling, printed labeling artworks, and other assigned labeling documents.
  • Originate precedent searches, create and maintain labeling comparisons, and assist in analysis of competitive labeling.
  • Interact with Marketing Company colleagues regarding global artworks as appropriate.
  • Process and prepare all US Final Printed Labeling and required EU specimens for submission.
  • Participate in the development and maintenance of work practices, templates, and associated documents relating to the labeling function.
  • Liaise with relevant stakeholders as needed to resolve critical labeling issues.
  • Represent functional expertise at relevant department meetings and relevant cross-functional subteams.
Desired Qualifications
  • Experience in packaging/artwork development and management as well as labeling development and/or maintenance.

AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatment; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before reaching the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and forming strategic partnerships, such as their Open Innovation program, which allows collaboration with the scientific community to speed up drug discovery. The company's goal is to advance healthcare by creating effective treatments for serious diseases and expanding their product offerings through innovation and collaboration.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery enhances AstraZeneca's R&D efficiency.
  • Real-world evidence streamlines AstraZeneca's drug approval processes.
  • Personalized medicine aligns with AstraZeneca's focus on precision therapies.

What critics are saying

  • Class-action lawsuit over Soliris could lead to financial penalties.
  • AI tool for breast cancer screening may face effectiveness challenges.
  • Foreign investment regulations in France may impact Dunkirk expansion.

What makes AstraZeneca unique

  • AstraZeneca excels in oncology, cardiovascular, and respiratory therapy areas.
  • The A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • Open Innovation program accelerates drug discovery through shared resources.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Cision
Apr 22nd, 2025
Enhertu Combination Improved Pfs In 1L Her2+ Mbc

Enhertu combination improved PFS in 1L HER2+ mBC

Life Sciences IP Review
Apr 17th, 2025
AstraZeneca unit faces class-action suit over alleged Soliris monopoly

AstraZeneca unit faces class-action suit over alleged soliris monopoly.

Our Health Needs
Apr 11th, 2025
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

Medical Update Online
Apr 11th, 2025
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025

AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.

Cision
Apr 11th, 2025
Result Of Agm

11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast

INACTIVE